Mumbai, 9th October 2025 – Fredun Pharmaceuticals Limited (FPL), a leading pharmaceutical formulation manufacturer diversified into generics, cosmeceuticals, nutraceuticals, mobility, and animal healthcare products, has announced the strategic acquisition of all assets of Wagr.ai, a pioneering pet tech platform. The move marks the creation of India’s first truly neutral online marketplace for pet products and services, combining FPL’s expertise in pet nutrition with Wagr’s advanced technology ecosystem.
Through this acquisition, FPL gains access to Wagr’s extensive digital assets, including its AI-powered pet care platform, 140,000+ registered pet parents, patented pet fitness tracking technology, and established veterinary network. This positions FPL at the forefront of India’s rapidly expanding $6 billion pet care industry, projected to grow at a 22% CAGR through 2030.
The company plans to relaunch the Wagr marketplace and services in Q4 FY 2025-26, providing an unbiased platform that hosts both emerging and established pet care brands. Unlike typical e-commerce models, FPL’s neutrality stems from its absence in dry food and biscuit segments, allowing it to host competing brands while ensuring that all transactions contribute to its consolidated revenue stream.
The integrated platform will also introduce on-demand telemedicine, enabling pet parents to connect with veterinarians via 15-minute video consultations, a service that has already facilitated over 11,000 sessions. Additionally, FPL aims to expand the Pan-India doctor network and educational programs for veterinary professionals. The platform’s AI chatbot, Toto, the world’s first of its kind, has already answered over 10,000 pet-related queries, offering real-time, personalized guidance.
Building on Wagr’s earlier innovations, FPL will reintroduce India’s first GPS and fitness tracker for dogs in FY 2026-27. The device will provide real-time health and activity insights through AI-driven analytics and app-based visualization, reinforcing the company’s tech-enabled approach to pet wellness.
Commenting on the development, Fredun Medhora, Managing Director, FPL, said, “This acquisition marks a transformative milestone for India’s pet care industry. By merging our expertise in pet nutrition with Wagr’s technology and reach, we are creating a neutral, all-encompassing ecosystem that serves pet parents, brands, and veterinarians alike. Our goal is to ensure that every pet in India benefits from a Fredun product or service.”
Siddharth Darbha, Co-founder of Wagr, added, “Wagr has always stood for trusted, compassionate pet care. With Fredun Pharma’s commitment to wellness, this mission will reach many more pet families.” Advaith Mohan, Co-founder of Wagr, remarked, “Seeing Wagr grow under Fredun Pharma feels like sending it to a bigger, more capable family.”
The acquisition, completed from Wagr’s founders and investors including IvyCap Ventures, Inflection Point Ventures, and Stanford Angels & Entrepreneurs, strengthens FPL’s foothold in the evolving pet care space.
With this strategic integration, Fredun Pharmaceuticals Limited aims to transform India’s pet ecosystem into a connected, intelligent, and inclusive space—bridging nutrition, healthcare, and technology to deliver holistic well-being for pets nationwide.
